Natco Pharma Limited - Asset Resilience Ratio

Latest as of September 2025: 63.89%

Natco Pharma Limited (NATCOPHARM) has an Asset Resilience Ratio of 63.89% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Natco Pharma Limited (NATCOPHARM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs66.64 Billion

≈ $720.63 Million USD Cash + Short-term Investments

Total Assets

Rs104.30 Billion

≈ $1.13 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Natco Pharma Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see NATCOPHARM total asset value.

Liquid Assets Composition Over Time

This chart breaks down Natco Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore NATCOPHARM long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs26.90 Billion	25.79%
Short-term Investments	Rs39.73 Billion	38.09%
Total Liquid Assets	Rs66.64 Billion	63.89%

Asset Resilience Insights

Very High Liquidity: Natco Pharma Limited maintains exceptional liquid asset reserves at 63.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Natco Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Natco Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Torrent Pharmaceuticals Limited NSE:TORNTPHARM	Drug Manufacturers - Specialty & Generic	2.79%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	2.51%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Harbin Pharmaceutical Group Co Ltd SHG:600664	Drug Manufacturers - Specialty & Generic	0.97%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Natco Pharma Limited (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Natco Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	31.76%	Rs27.41 Billion ≈ $296.48 Million	Rs86.31 Billion ≈ $933.39 Million	+6.95pp
2024-03-31	24.82%	Rs17.14 Billion ≈ $185.36 Million	Rs69.06 Billion ≈ $746.89 Million	-0.06pp
2023-03-31	24.88%	Rs14.07 Billion ≈ $152.19 Million	Rs56.57 Billion ≈ $611.83 Million	+12.18pp
2022-03-31	12.70%	Rs6.49 Billion ≈ $70.17 Million	Rs51.09 Billion ≈ $552.53 Million	-3.83pp
2021-03-31	16.53%	Rs7.92 Billion ≈ $85.64 Million	Rs47.92 Billion ≈ $518.23 Million	-2.71pp
2020-03-31	19.24%	Rs8.83 Billion ≈ $95.46 Million	Rs45.88 Billion ≈ $496.15 Million	-4.68pp
2019-03-31	23.92%	Rs10.29 Billion ≈ $111.31 Million	Rs43.03 Billion ≈ $465.36 Million	+1.72pp
2018-03-31	22.20%	Rs8.25 Billion ≈ $89.18 Million	Rs37.15 Billion ≈ $401.77 Million	+17.29pp
2017-03-31	4.91%	Rs1.14 Billion ≈ $12.30 Million	Rs23.18 Billion ≈ $250.64 Million	+3.76pp
2016-03-31	1.15%	Rs209.64 Million ≈ $2.27 Million	Rs18.24 Billion ≈ $197.24 Million	+1.14pp
2015-03-31	0.01%	Rs1.18 Million ≈ $12.79K	Rs13.84 Billion ≈ $149.68 Million	-0.02pp
2014-03-31	0.03%	Rs3.18 Million ≈ $34.39K	Rs11.96 Billion ≈ $129.31 Million	-0.05pp
2013-03-31	0.08%	Rs8.12 Million ≈ $87.83K	Rs10.80 Billion ≈ $116.84 Million	-0.01pp
2012-03-31	0.08%	Rs7.37 Million ≈ $79.76K	Rs9.03 Billion ≈ $97.63 Million	-9.70pp
2011-03-31	9.78%	Rs691.96 Million ≈ $7.48 Million	Rs7.07 Billion ≈ $76.49 Million	+1.43pp
2010-03-31	8.36%	Rs460.41 Million ≈ $4.98 Million	Rs5.51 Billion ≈ $59.58 Million	-8.29pp
2009-03-31	16.65%	Rs859.93 Million ≈ $9.30 Million	Rs5.17 Billion ≈ $55.86 Million	+2.77pp
2008-03-31	13.88%	Rs581.93 Million ≈ $6.29 Million	Rs4.19 Billion ≈ $45.36 Million	-2.82pp
2007-03-31	16.69%	Rs583.87 Million ≈ $6.31 Million	Rs3.50 Billion ≈ $37.83 Million	+2.74pp
2006-03-31	13.95%	Rs429.69 Million ≈ $4.65 Million	Rs3.08 Billion ≈ $33.30 Million	-1.36pp
2005-03-31	15.31%	Rs439.99 Million ≈ $4.76 Million	Rs2.87 Billion ≈ $31.08 Million	--

pp = percentage points

About Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

Rs145.98 Billion INR

Market Cap Rank

#7111 Global

#340 in India

Share Price

Rs815.05

Change (1 day)

-0.15%

52-Week Range

Rs792.95 - Rs1206.00

All Time High

Rs1591.09